Tag:
product recall
Latest Headlines
Latest Headlines
UPDATED: Baxter bitten again by problems with Colleague infusion pumps
The company says it was served a subpoena in March by the SEC which wants info "related to the company's accounting treatment, financial reporting and disclosures relating to the remediation and recall of the company's Colleague and Syndeo infusion pumps," MassDevice reports.
J&J pulls infant Tylenol on dosing-system issue
Johnson & Johnson's consumer healthcare unit is recalling another children's Tylenol product. This time, it's not manufacturing failures spurring the recall, but a dosing system that...
FDA: Novartis plant shows patterns of problems
Health Canada on Friday advised Canadians that they should return certain Excedrin Extra Strength and Tension Headache caplets, just as drug giant Novartis ( $NVS ) advised U.S. consumers to do last
J&J tarnished in Texas trial, FDA warning
It hasn't been a good week for Johnson & Johnson's ( $JNJ ) reputation. As jurors in Texas were listening to allegations that J&J's Janssen unit defrauded the state by systematically misleading
Novartis recall hints at regulatory snowball
Uh-oh. Novartis ( $NVS ) is recalling some OTC drugs made at a Nebraska plant that was recently shut down for maintenance and upgrades. The voluntary recall is one thing. But the recall's timing, so
Parents allege J&J's excess-API Tylenol killed son
An Ellensburg, WA, couple who suffered the loss of a 2-year-old to liver failure is suing Johnson & Johnson ($JNJ) , saying that manufacturing problems leading to Tylenol recalls in 2010 are to
Rockline quietly recalls contaminated wipes
Contaminated wipes are making headlines again, but this time the hot seat is occupied by Wisconsin-based Rockline Industries. The company's baby wipes recall marks its fifth in a decade, occurring in
Actavis, Mylan continue defense in Digitek API suits
The family of a heart patient who died while taking atrial-fibrillation drug Digitek is appealing a West Virginia judge's ruling exonerating manufacturer Actavis and distributor Mylan ( $MYL ). Quality
Europe issues 2nd recall of drugs made by Ben Venue
Ben Venue is back in the news for product quality shortcomings with Europe's recommendation Friday of additional precautionary drug recalls. The European Medicines Agency issued a similar recall for
Europe takes precautions with Ben Venue drugs
Ben Venue 's manufacturing QA troubles, which prompted the voluntary closing of its Bedford, OH plant, have rippled across the Atlantic. The European Medicines Agency issued a precautionary recall of
